HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xin Huang Selected Research

asialo-von Willebrand Factor

4/2021Dihydroartemisinin inhibits the expression of von Willebrand factor by downregulation of transcription factor ERG in endothelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xin Huang Research Topics

Disease

265Neoplasms (Cancer)
07/2022 - 03/2002
61Breast Neoplasms (Breast Cancer)
07/2022 - 01/2005
39Hypoxia (Hypoxemia)
01/2022 - 01/2007
35Inflammation (Inflammations)
09/2022 - 08/2008
34Infections
05/2022 - 12/2010
30Neoplasm Metastasis (Metastasis)
05/2022 - 06/2003
22Fibrosis (Cirrhosis)
10/2022 - 08/2000
21Hepatocellular Carcinoma (Hepatoma)
06/2022 - 03/2002
20Osteosarcoma (Osteogenic Sarcoma)
06/2022 - 03/2005
20Carcinogenesis
01/2022 - 10/2006
19Leukemia
07/2022 - 03/2008
18Body Weight (Weight, Body)
01/2021 - 11/2007
17Carcinoma (Carcinomatosis)
01/2022 - 07/2005
16Myasthenia Gravis
01/2022 - 08/2008
15Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2022 - 09/2010
14Lung Neoplasms (Lung Cancer)
06/2022 - 12/2011
14Colorectal Neoplasms (Colorectal Cancer)
05/2022 - 08/2007
13Myocardial Infarction
09/2022 - 12/2016
13Stomach Neoplasms (Stomach Cancer)
05/2022 - 05/2005
13Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 04/2016
12Hemorrhage
02/2022 - 08/2010
12COVID-19
01/2022 - 01/2020
12Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 03/2013
12Sepsis (Septicemia)
01/2022 - 03/2007
12Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
03/2021 - 11/2010
12Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2021 - 11/2010
11Pain (Aches)
01/2022 - 12/2007
10Insulin Resistance
09/2022 - 05/2016
10Renal Cell Carcinoma (Grawitz Tumor)
05/2022 - 02/2005
10Pancreatic Neoplasms (Pancreatic Cancer)
03/2022 - 02/2009
10Virus Diseases (Viral Diseases)
02/2022 - 01/2009
10Hypertension (High Blood Pressure)
10/2021 - 08/2009
9Uterine Cervical Neoplasms (Cancer of the Cervix)
06/2022 - 05/2003
9Thrombosis (Thrombus)
04/2021 - 01/2017
9Lymphatic Metastasis
01/2020 - 04/2009
8Necrosis
05/2022 - 07/2010
8Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
01/2022 - 05/2015
8Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 07/2015
8Disease Progression
12/2021 - 06/2012
8Obesity
10/2021 - 08/2004
8Type 2 Diabetes Mellitus (MODY)
01/2021 - 01/2012
7Periodontitis
06/2022 - 10/2016
7Rheumatoid Arthritis
04/2022 - 03/2014
7Endometriosis
02/2022 - 03/2013
7Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 08/2012
7Endometrial Neoplasms (Endometrial Cancer)
01/2022 - 03/2011

Drug/Important Bio-Agent (IBA)

85Proteins (Proteins, Gene)FDA Link
09/2022 - 03/2005
62Biomarkers (Surrogate Marker)IBA
05/2022 - 09/2005
40Pharmaceutical PreparationsIBA
06/2022 - 08/2009
31MicroRNAs (MicroRNA)IBA
05/2022 - 04/2010
30Biological ProductsIBA
03/2022 - 07/2005
29Messenger RNA (mRNA)IBA
09/2022 - 04/2002
23CytokinesIBA
04/2022 - 03/2008
22Sunitinib (Sutent)FDA Link
01/2016 - 10/2007
20Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2022 - 07/2005
19palbociclibIBA
01/2022 - 01/2015
17Hormones (Hormone)IBA
01/2022 - 01/2012
16Glucose (Dextrose)FDA LinkGeneric
09/2022 - 11/2010
15Circular RNAIBA
06/2022 - 01/2019
14RNA (Ribonucleic Acid)IBA
03/2022 - 12/2014
14PlatinumIBA
02/2022 - 01/2018
13Long Noncoding RNAIBA
01/2022 - 05/2015
13triptolideIBA
03/2021 - 01/2008
13DNA (Deoxyribonucleic Acid)IBA
01/2021 - 05/2003
12Small Interfering RNA (siRNA)IBA
03/2022 - 02/2009
12Therapeutic UsesIBA
02/2022 - 07/2003
11EnzymesIBA
09/2022 - 05/2004
11Interleukin-6 (Interleukin 6)IBA
09/2022 - 05/2003
11Cisplatin (Platino)FDA LinkGeneric
03/2022 - 02/2011
11Oxygen (Dioxygen)IBA
02/2022 - 01/2007
11ErbB Receptors (EGF Receptor)IBA
01/2022 - 05/2007
11salicylhydroxamic acid (SHAM)IBA
11/2021 - 10/2005
10LipidsIBA
05/2022 - 01/2011
10Fulvestrant (Faslodex)FDA Link
01/2022 - 01/2018
10CateninsIBA
01/2022 - 06/2013
10LigandsIBA
01/2021 - 08/2007
9Transcription Factors (Transcription Factor)IBA
05/2022 - 12/2012
9Retinaldehyde (Retinal)IBA
12/2021 - 09/2006
9AntigensIBA
01/2021 - 02/2005
8Tyrosine Kinase InhibitorsIBA
01/2022 - 09/2009
8LipopolysaccharidesIBA
01/2022 - 10/2014
8ParaffinIBA
06/2021 - 04/2004
8Estrogen ReceptorsIBA
01/2021 - 06/2007
7Peptides (Polypeptides)IBA
05/2022 - 01/2016
7AcidsIBA
04/2022 - 01/2012
7PolymersIBA
03/2022 - 01/2016
7Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 02/2016
7Caspase 3 (Caspase-3)IBA
09/2021 - 11/2005

Therapy/Procedure

133Therapeutics
05/2022 - 07/2003
52Drug Therapy (Chemotherapy)
01/2022 - 10/2007
18Radiotherapy
06/2022 - 04/2012
11Ligation
10/2021 - 01/2012
9Immunotherapy
12/2021 - 02/2005
8Aftercare (After-Treatment)
01/2022 - 11/2011
8Percutaneous Coronary Intervention
01/2022 - 09/2016
8Neoadjuvant Therapy
10/2020 - 02/2011
7Length of Stay
02/2022 - 12/2007
7Precision Medicine
02/2022 - 01/2017
7Lasers (Laser)
01/2022 - 01/2013
7Stents
05/2021 - 05/2017